
<DOC>
<DOCNO>WT01-B12-4</DOCNO>
<DOCOLDNO>IA049-000856-B012-391</DOCOLDNO>
<DOCHDR>
http://www.rx-compound.com:80/mortar.htm 206.8.11.82 19970210114914 text/html 9535
HTTP/1.0 200 OK
Date: Mon, 10 Feb 1997 11:22:07 GMT
Server: Apache/1.0.0
Content-type: text/html
Content-length: 9364
Last-modified: Fri, 22 Nov 1996 16:07:06 GMT
</DOCHDR>
<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 2.0">
<title>The Mortar and Pestle(c) Industry News Letter - Internet Addition</title>
</head>

<body bgcolor="#C0C0C0">

<table border="0" width="100%">
    <tr>
        <td width="600" bgcolor="#AFD0AC"><img
        src="images/themort2.gif" width="568" height="200"></td>
        <td width="50">&nbsp;</td>
    </tr>
</table>

<table border="0" cellpadding="2" cellspacing="4" width="100%">
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC"><p
        align="center">&nbsp; </p>
        </td>
        <td valign="top" width="50%" bgcolor="#FFFFFF">&nbsp;</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC"><img
        src="images/themort3.gif" width="100" height="100"></td>
        <td valign="top" width="50%" bgcolor="#FFFFFF"><font
        size="5"><strong>T</strong></font><font size="4"><strong>HE</strong></font><font
        size="5"><strong> M</strong></font><font size="4"><strong>ORTAR</strong></font><font
        size="5"><strong> A</strong></font><font size="4"><strong>ND</strong></font><font
        size="5"><strong> P</strong></font><font size="4"><strong>ESTLE</strong></font><font
        size="5"><strong> - O</strong></font><font size="4"><strong>CTOBER
        1996, ISSUE 6 -</strong></font> TBA</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC"><img
        src="images/themort3.gif" width="100" height="100"></td>
        <td valign="top" width="50%" bgcolor="#FFFFFF"><font
        size="5"><strong>T</strong></font><font size="4"><strong>HE</strong></font><font
        size="5"><strong> M</strong></font><font size="4"><strong>ORTAR</strong></font><font
        size="5"><strong> A</strong></font><font size="4"><strong>ND</strong></font><font
        size="5"><strong> P</strong></font><font size="4"><strong>ESTLE</strong></font><font
        size="5"><strong> - September</strong></font><font
        size="4"><strong> 1996, </strong></font><a
        href="mpissue5.htm"><font size="4"><strong>ISSUE 5</strong></font></a><font
        size="4"><strong> - </strong></font><font size="3">Professional
        Pharmacists Respond To The Challenge to improve the
        effectiveness of medication therapy by providing
        Pharmaceutical Care. - Ginger for Motion Sickness? - Dextrometorphan
        attenuates and reverses morphine tolerance. - Intranasal
        lidocaine for migraine - 4-Aminopyridine for Fatigue of
        MS by Michele Mass, M.D., Neuroimmunology, Oregon Health
        Sciences University, MS Center of Oregon.</font></td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC"><img
        src="images/themort3.gif" width="100" height="100"></td>
        <td valign="top" width="50%" bgcolor="#FFFFFF"><font
        size="5"><strong>T</strong></font><font size="4"><strong>HE</strong></font><font
        size="5"><strong> M</strong></font><font size="4"><strong>ORTAR</strong></font><font
        size="5"><strong> A</strong></font><font size="4"><strong>ND</strong></font><font
        size="5"><strong> P</strong></font><font size="4"><strong>ESTLE</strong></font><font
        size="5"><strong> - August</strong></font><font size="4"><strong>
        1996, </strong></font><a href="mpissue4.htm"><font
        size="4"><strong>ISSUE 4</strong></font></a><font
        size="4"><strong> -</strong></font><font size="3"> Individualized
        Therapy For Weight Control: Affecting Outcomes In Major
        Disease States - Ina landmark study, Weintraub et al. at
        the University of Rochester studied the effects of phentermine
        15mg/day plus fenfluramine 60mg/day (versus placebo) in
        121 patients who weighed 120% to 180% of their
        &quot;ideal weight.&quot; - Topical Ketoprofen for
        Chronic Pain by Susannah Sterling, R,N., C. C. M,
        Rehabilitation Specialist, Kingston, PA</font></td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC"><img
        src="images/themort3.gif" width="100" height="100"></td>
        <td valign="top" width="50%" bgcolor="#FFFFFF"><font
        size="5"><strong>T</strong></font><font size="4"><strong>HE</strong></font><font
        size="5"><strong> M</strong></font><font size="4"><strong>ORTAR</strong></font><font
        size="5"><strong> A</strong></font><font size="4"><strong>ND</strong></font><font
        size="5"><strong> P</strong></font><font size="4"><strong>ESTLE</strong></font><font
        size="5"><strong> - J</strong></font><font size="4"><strong>ULY
        1996, </strong></font><a href="mpissue3.htm"><font
        size="4"><strong>ISSUE 3</strong></font></a><font
        size="4"><strong> - </strong></font><font size="3">We&#146;re
        Talking About SERVICE - Customized medications to meet
        each patient&#146;s specific need - Pluronic Lecithin
        Organogel &amp; Transdermal Drug Transport - Natural
        Progesterone: The Multiple Roles of a Remarkable Hormone
        - Recurrent Wheezing in Children by John Rogers, M.D.
        Pediatric Pulmonology Childrens Hospital, Knoxville, TX</font></td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC"><img
        src="images/themort3.gif" width="100" height="100"></td>
        <td valign="top" width="50%" bgcolor="#FFFFFF"><font
        size="5"><strong>T</strong></font><font size="4"><strong>HE</strong></font><font
        size="5"><strong> M</strong></font><font size="4"><strong>ORTAR</strong></font><font
        size="5"><strong> A</strong></font><font size="4"><strong>ND</strong></font><font
        size="5"><strong> P</strong></font><font size="4"><strong>ESTLE</strong></font><font
        size="5"><strong> - J</strong></font><font size="4"><strong>UNE
        1996, </strong></font><a href="mpissue2.htm"><font
        size="4"><strong>ISSUE 2</strong></font></a><font
        size="4"><strong> -</strong></font> Impotence &quot;Triple
        Therapy&quot; - Lip Balms - DHE Nasal Spray &amp;
        Migraine - The Right Medication in the Right Doses by
        Gene Lawrence, M.D., Obstetrics and Gynecology, Newport
        Beach, CA</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC"><img
        src="images/themort3.gif" width="100" height="100"></td>
        <td valign="top" width="50%" bgcolor="#FFFFFF"><font
        size="5"><strong>T</strong></font><font size="4"><strong>HE</strong></font><font
        size="5"><strong> M</strong></font><font size="4"><strong>ORTAR</strong></font><font
        size="5"><strong> A</strong></font><font size="4"><strong>ND</strong></font><font
        size="5"><strong> P</strong></font><font size="4"><strong>ESTLE</strong></font><font
        size="5"><strong> - M</strong></font><font size="4"><strong>AY
        1996, </strong></font><a href="mpissue1.htm"><font
        size="4"><strong>ISSUE 1</strong></font></a> <font
        size="4"><strong>-</strong></font> <font size="3">Welcome
        to the first edition of &quot;THE MORTAR AND PESTLE&quot;</font><font
        size="4"> </font>- Topical NSAID Therapy - DHEA-Dehydroepiandrosterone
        - Transderm Scop-Where Are You? - Topical Therapy for Onychomycosis
        by Bruce Berger, M.D., Dermatologist, Princeton, NJ</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC">&nbsp;</td>
        <td valign="top" width="50%" bgcolor="#FFFFFF">&nbsp;</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC">&nbsp;</td>
        <td valign="top" width="50%" bgcolor="#FFFFFF">&nbsp;</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC">&nbsp;</td>
        <td valign="top" width="50%" bgcolor="#FFFFFF">&nbsp;</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC">&nbsp;</td>
        <td valign="top" width="50%" bgcolor="#FFFFFF">&nbsp;</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC">&nbsp;</td>
        <td valign="top" width="50%" bgcolor="#FFFFFF">&nbsp;</td>
    </tr>
    <tr>
        <td align="center" width="100" bgcolor="#AFD0AC">&nbsp;</td>
        <td valign="top" width="50%" bgcolor="#FFFFFF">&nbsp;</td>
    </tr>
</table>

<p align="center"><a href="info.htm"><font size="4">Information</font></a><font
size="4"> | </font><a href="guestreg.htm"><font size="4">Free
e-mail Mailing List</font></a></p>

<p align="center"><a href="mortar.htm"><font size="4">The Mortar
and Pestle© Industry Newsletter</font></a></p>

<p align="center">&nbsp;<a href="index.htm"><font size="4">Professional
Compounding Pharmacy</font></a></p>

<p align="center">&nbsp;<a href="http://www.microsoft.com/ie/"><font
size="4"><img src="images/ie_static.gif" border="0" width="88"
height="31"></font></a></p>

<p>&nbsp;</p>

<p><font size="2">Web and Graphic Design by William
Neuenschwander Consulting Group @ </font><a
href="http://www.xplosiv.com"><font size="2">XPLOSIV
COMMUNICATIONS</font></a></p>
</body>
</html>
</DOC>